20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10643 | C-Fms-IN-1 | c-Fms | |
c-Fms-IN-1 is an inhibitor of c-FMS kinase (IC50 = 0.8 nM). | |||
T10775 | C-Fms-IN-2 | c-Fms | |
c-Fms-IN-2 is an inhibitor of c-FMS kinase (IC50 = 24 nM). | |||
T10649 | C-Fms-IN-3 | c-Fms | |
c-Fms-IN-3 is a novel inhibitor of the c-FMS and can be used in studies about antirheumatic and anti-inflammatory diseases. | |||
T61589 | C-Fms-IN-13 | c-Fms | |
c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50= 17 nM). c-Fms-IN-13 is an anti-inflammatory agent. | |||
T10648 | C-Fms-IN-9 | c-Fms | |
c-Fms-IN-9 is a c-FMS inhibitor. It inhibits unphosphorylated c-FMS kinase (uFMS) and uKIT (IC50s: <0.01 μM and 0.1-1 μM). | |||
T10646 | C-Fms-IN-7 | Others | |
c-Fms-IN-7 is a cFMS inhibitor (IC50: 18.5 nM). | |||
T10645 | C-Fms-IN-6 | c-Fms | |
c-Fms-IN-6 is a potent inhibitor of c-FMS (IC50 ≤10 nM for unphosphorylated c-FMS) and also weakly inhibits unphosphorylated c-KIT and PDGFR (IC50: > 1 μM). | |||
T10647 | C-Fms-IN-8 | CSF-1R | |
c-Fms-IN-8 is a colony-stimulating factor-1 receptor (CSF-1R, c-FMS) Type II inhibitor (IC50: 9.1 nM). It is compound 4a in the reference. | |||
T10644 | C-Fms-IN-10 | Others | |
c-Fms-IN-10 is the derivative of thieno [3,2-d] pyrimidine, a kinase inhibitor of FMS (Colony-stimulating factor-1 receptor, CSF-1R; IC50: 2 nM) with anti-tumor activity. | |||
T64050 | C-Fms-IN-12 | ||
c-Fms-IN-12 is an FMS kinase inhibitor that also inhibits c-KIT and induces apoptosis in A549 cells. c-Fms-IN-12 is a potential broad-spectrum anti-cancer agent that has demonstrated therapeutic effects in a variety of c... | |||
T79815 | C-Fms-IN-14 | c-Fms | |
c-Fms-IN-14 (Example 76) is a potent inhibitor of the c-Fms kinase with an IC50 of 4 nM, utilized in cancer and autoimmune disease research [1]. | |||
T27345 | FMS586 | FMS-586,FMS 586 | |
FMS586 is a selective antagonist of neuropeptide Y Y5 receptor with oral activity. | |||
T2620 | G-749 | G749 | Apoptosis , FLT , c-RET , TAM Receptor , Aurora Kinase |
G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants. | |||
T5586 | CFMS Receptor Inhibitor II | c-Fms | |
cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor | |||
T2340 | AC1NS4RE | Tyrosinase | |
It is a tyrosine kinase inhibitor. | |||
T4209 | TAK-659 hydrochloride | TAK-659 | VEGFR , FLT , Tyrosine Kinases , JAK , Syk |
TAK-659 hydrochloride (TAK-659) is a potent and selective inhibitor of spleen tyrosine kinase (SYK) with an IC50 value of 3.2 nM. It is selective against most other kinases, but potent toward both SYK and FLT3. | |||
T1938 | FLT3-IN-2 | FLT | |
FLT3-IN-2 is an FLT3 inhibitor (IC50<1 μM). | |||
T4428 | CCT241736 | FLT , Aurora Kinase | |
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3, CCT241736, an advanced analog of CCT137690, is a preclinica... | |||
T10894 | CSF1R-IN-1 | c-Fms | |
CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM. | |||
T2272 | BPR1J-097 | BPR1J097 | FLT |
BPR1J-097) is a novel FLT-3 inhibitor(IC50: 11±7 nM) with promising in vivo anti-tumor activities. It also inhibits FLT-3 D835Y (IC50: 3 nM). |